(Q63399090)

English

HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

Phase 1 Study of HER2-Specific CAR T Cell Locoregional Immunotherapy for HER2 Positive Recurrent/Refractory Pediatric Central Nervous System Tumors (English)
0 references
0 references
0 references
0 references
26 July 2018
0 references
26 July 2021
0 references
36
0 references
26 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit